ArticleOncotarget2013

Inhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas In vitro and In vivo.

Shuang Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.